PFE
Pfizer Inc.
New York Stock Exchange$52.03
Open: $52.08 High: $52.09 Low: $51.26 Close: $52.063
Range: 2022-06-27 - 2022-06-28
Volume:3,329,020Market: Extended-hours
Powered by Finage Stock APIDelayed data
PFE
Pfizer Inc. 235 E 42ND ST https://www.pfizer.com
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 vaccine sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.- CEO: Ian C. Read
- Employees: 79,000
- Sector: Healthcare
- Industry: Drug Manufacturers
PFE News
Latest news about the PFE
- 7 High-Quality Large Cap Stocks to Buy at a Discount
These large-cap stocks offer explosive upside and are trading at a remarkable discount
by Investor Place at 6/14/22, 12:00 AMView More → - 7 Stocks Under $50 to Buy and Hold Forever
Investors searching for stocks under $50 should strongly consider the names on this list.
by Investor Place at 6/9/22, 12:00 AMView More →